Company / Current Assets
Cogent Biosciences, Inc. Current Assets History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$910.4M
FY2025
5-year range
$222.6M / $910.4M
FY2021-FY2025
Trend
+207.1%
vs FY2024
Sector context
#58 of 213
Health Care
What the data says
Current Assets changed +207% YoY in FY2025, a notable deviation from the 8-year average annual change of +97%.
Based on SEC 10-K filings.
$910M in FY2025 with a 5-year CAGR of +30.0%.
Improved from $271M to $910M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +50.9%
- 5-Year CAGR
- +30.0%
- 10-Year CAGR
- -
Sector benchmark
#58 of 213 in Health CareTop 27% of 213This company $910.4M Sector average $2.5B
▼
-63.9% below sector average
Key checks
Key Insights
- Cogent Biosciences, Inc.'s current assets has grown for 4 consecutive years.
- 5-year CAGR of +30.0%, indicating consistent growth.
- In FY2025, current assets increased 207.1% year-over-year.
- Ranks #58 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.43 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $910.4M | +207.1% |
| FY2024 | $296.5M | +9.5% |
| FY2023 | $270.8M | +2.2% |
| FY2022 | $265.0M | +19.0% |
| FY2021 | $222.6M | -9.1% |
| FY2020 | $244.9M | +503.4% |
| FY2019 | $40.6M | -49.9% |
| FY2018 | $81.0M | +91.1% |
| FY2017 | $42.4M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026